| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972136 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
The use of a TIAP showed long-lasting port survival and relatively low complication rates. Our data suggest that the TIAP is well suited for continuous intravenous epoprostenol delivery in patients with pulmonary hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael G. BS, Elisabeth H. MD, PhD, Anco MD, PhD, Anton MD, PhD, Repke J. MD, Rolf M.F. MD, PhD,